While clinical data suggests that LIGHT is upregulated in IBD and that it correlates with inflammation, preclinical models reveal a more complex picture, with both pathogenic and protective roles that vary depending on disease stage and cellular context. The gene discussed is TNFSF14; the disease is inflammatory bowel disease.